Tuesday, 10 September 2019


08:30 - 12:00

  • LC-04-001-Update of the ISSVA classification
  • LC-04-002-Benign vascular tumours
  • LC-04-003-Borderline and malignant vascular tumours
  • LC-04-006-Provisionally unclassified vascular anomalies
  • MD-05-001-Differentially expressed immune related genes in metastatic vs. non-metastatic LUMA, LUMB1 and TNBC primary breast carcinoma cases
  • MD-06-001-Signal: the homepage of mutational signatures
  • MD-06-002-A new user-friendly web application to implement mutational signatures analysis
  • OFP-09-001-Adult clinical necropsies: the gold standard of clinical practice are decreasing worldwide. And in Coimbra? A retrospective study from 2007 to 2018 comparing clinical and autopsy diagnoses
  • OFP-09-002-Morphological and virological diagnostics of myocarditis in patients with hypertrophic cardiomyopathy
  • OFP-09-003-Canonical recognition and on-site palaeopathologic study of the Blessed Vincenzo dell'Aquila (1430-1504)
  • OFP-09-004-Paleopathology of two mummified bodies from the Takarkori rock shelter (SW Libya, 6100-5600 years BP)
  • OFP-09-005-Histopathology and DNA evaluation of wet specimens from the Pathology Collection of Turin
  • OFP-09-006-The historical roots of theranostic revealed by the genealogical and phylogenetic portrayal of tumours by pathologists
  • OFP-09-007-Scorenado: a customisable, user-friendly and open-source visual assessment tool for histological slides
  • OFP-09-008-Complete digital pathology for routine histopathology diagnosis: 2 years' experience at Granada University Hospitals, Spain
  • OFP-09-009-Digital immunohistochemical evaluation of PDL1 in lung carcinomas highly correlates with manual method
  • OFP-09-011-Pathology teaching: the use of art and active methodologies
  • OFP-09-012-Morphological features of liver biopsies from The Gambia, West Africa: first pathology report from the "Gambia Hepatitis Intervention Study" by the International Agency for Research on Cancer
  • OFP-09-014-A nationwide pulmonary carcinoid tumour cohort collected from the Finnish clinical pathology integrated biobanks
  • OFP-10-001-Vascular endothelial growth factor (VEGF) and its receptors expression in lung carcinoids: clinicopathological correlation
  • OFP-10-002-Biomarkers in lung cancer: descriptive analysis of a centralised platform in Spain (Lungpath)
  • OFP-10-004-Interlaboratory variation in PD-L1 positivity in histological and cytological material of non-small cell lung cancer patients
  • OFP-10-006-The new gold standard for detection of theranostic gene rearrangements in thoracic oncology is born: one-year prospective routine LD-RTPCR in 328 newly-diagnosed lung adenocarcinomas
  • OFP-10-007-Birt-Hogg-Dubé (BHD) syndrome-associated lung cysts: histopathological analysis and differential diagnosis from miscellaneous cystic lung diseases
  • OFP-10-008-Combined assessment of tumour mutational load, CD8+ T cell infiltration, and expression of PD-L1 and HLA class I in small biopsy specimens to predict immunotherapy response in non-small cell lung cancer
  • OFP-10-009-Decreased PD-L1 immunostaining in cytological NSCLC specimens after fixation in an ethanol based fixative
  • OFP-10-010-Interstitial lung disease in systemic sclerosis is associated with autoimmunity to α1(V) chain of type V collagen
  • OFP-10-011-Multivariate survival analysis reveals RAD51 protein as a superior prognostic factor compared to tumor infiltrating lymphocytes and PD-L1 expression in patients with resected non-small-cell lung carcinoma
  • OFP-10-012-Copy number variation by NGS predict HER2 amplification status by ISH in NSCLC
  • OFP-10-014-Visceral pleural invasion by tumour size, cancer type and pathologist in 1,560 resections
  • OFP-10-015-Interobserver variation in the classification of thymic lesions including biopsies and resection specimens in an international digital microscopy panel
  • SPEC-02-001-Case 1
  • SPEC-02-002-Case 2
  • SPEC-02-003-Case 3
  • SPEC-02-004-Case 4
  • SPEC-02-005-Case 5
  • SPEC-02-006-Case 6
  • SPEC-03-001-New concepts in histopathology of NASH
  • SPEC-03-002-Is there still room for liver biopsy in viral hepatitis?
  • SPEC-03-003-Role of liver biopsy in cholestatic liver diseases
  • SY-17-003-The new landscape of poorly differentiated NENs and mixed tumours
  • SY-17-004-Tumour heterogeneity and tumour progression in NENs
  • SY-17-005-New insights from lung NEN molecular data: new entities or new concepts?
  • SY-18-001-How the WHO Blue Books are handling hereditary cancer syndromes
  • SY-18-002-Overview of the digestive system syndromes
  • SY-18-003-Molecular classification from research to practice: two examples from the TCGA
  • SY-18-004-Familial colorectal cancer syndromes: the importance of registries and databases
  • SY-18-005-Lynch Syndrome and mismatch repair
  • SY-18-006-Identifying genetic syndromes – what is best practice
  • SY-19-001-Breast imaging: role and limitation
  • SY-19-002-Breast FNAC with rapid on-site diagnosis: potential & limitations
  • SY-19-003-Breast CNB: potential and limitations
  • SY-19-004-Prognostic and predictive factors from FNAC material using molecular tools
  • SY-19-006-Integrating the diagnostic of breast lesions

14:45 - 16:45

  • SC-08-001-Thyroiditis
  • SC-08-003-Poorly differentiated and anaplastic carcinoma
  • SC-08-004-Sporadic and familial medullary carcinoma
  • SC-08-005-Rare flowers
  • SC-09-001-Before gloves and antibiotics, a historical review from the daily life as a pathologist
  • SC-09-002-Biosafety in the autopsy room. Our experience
  • SC-09-003-Prion diseases and other health risks in neuropathology. How to handle autopsy material?
  • SS-09-001-Case 1
  • SS-09-003-Case 3
  • SS-09-004-Case 4
  • SS-09-005-Case 5
  • SS-09-006-Case 6
  • SS-09-007-Case 7
  • SS-10-002-Case 2
  • SS-10-003-Case 3
  • SS-10-004-Case 4
  • SS-10-006-Case 6
  • SS-10-007-Case 7
  • SS-10-008-Case 8
  • SS-10-009-Case 9
  • SS-11-001-Case 1
  • SS-11-003-Case 3
  • SS-11-004-Case 4
  • SS-11-005-Case 5
  • SS-11-007-Case 7
  • SS-11-008-Case 8
  • SS-11-009-Case 9
  • SY-20-001-Genomic insights in sarcomas
  • SY-20-003-Prognosis and grading of tumours in the molecular era
  • SY-20-004-Molecular diagnosis of tumours in a clinical context: a case-based approach
  • SY-20-005-Molecular testing vs morphology in sarcomas: what is left to pathologists?
  • VM-06-001-Case 1
  • VM-06-002-Case 2
  • VM-06-003-Case 3
  • VM-06-004-Case 4
  • VM-06-005-Case 5
  • VM-06-006-Case 6

17:15 - 19:15

  • MD-08-001-Gene fusions in melanoma and/or skin
  • MD-08-002-NanoString transcript analysis for the detection of gene fusion events
  • OFP-11-002-Contribution of Raman Spectroscopy to diagnosis and grading of chondrogenic tumours
  • OFP-11-003-Dedifferentiated liposarcoma with myxoid liposarcoma-like features and amplification of DNA damage-inducible transcript 3 (DDIT3) - an important diagnostic pitfall
  • OFP-11-004-Immunohistochemical analysis of 33 cases of chondroblastomas: a single institutional experience from India
  • OFP-11-005-Superficial CD34+ fibroblastic tumour: clinicopathological, molecular and cytogenetic study of 4 cases
  • OFP-11-007-INSM1 immunohistochemical expression in a large cohort of Ewing sarcoma family of tumours
  • OFP-11-011-Validation of PCR for the diagnosis of leprosy in patients from Kiribas
  • OFP-11-012-In-situ protein expression analysis of cancer testis antigen SSX2
  • OFP-12-001-Renal cell carcinoma in children and adolescent, a retrospective analysis of a cooperative European cohort
  • OFP-12-002-BRAF V600E mutation: a significant biomarker for prediction of disease in paediatric Langerhans cell histiocytosis
  • OFP-12-003-Histopathology of Steel syndrome due to new pathogenic variants of COL27A1 gene
  • OFP-12-004-Features of PLAP expression in placental structures during allogeniec pregnancy (surrogate maternity, oocyte donation) on the background of pre-eclampsia, as an indicator of exosomal trophoblast activity
  • OFP-12-005-The study of polymorphism of HLA genes as a predictor of the development of hypertensive complications of pregnancy
  • OFP-12-007-Perinatal acute respiratory failure: autopsy remains the best quality control tool
  • OFP-12-008-Body stalk anomaly: a rare lethal fetal anomaly, rarely reported in a dichorionic diamniotic twin pregnancy
  • OFP-12-010-Stillbirth and perinatal death: a retrospective study with application of ICD-PM to the autopsies performed between 2007 and 2018 in Coimbra
  • OFP-12-011-Metabolic reprogramming and altered isotope fractionation of cancerous cells of neural origin in the light of advanced atomic level Mass Spectrometry
  • OFP-12-012-Vascular anastomoses in monochorionic twin placentas: a pathomorphological study using CT
  • OFP-13-001-Expression of SOX11 in mantle cell lymphoma is associated with increased angiogenesis and immunosuppressive microenvironment
  • OFP-13-002-Prognostic role of the microenvironment in follicular lymphoma treated with Rituximab and Rituximab+lenalidomide - results of a translational study of the SAKK35/10 trial
  • OFP-13-003-PDL1 in lymphomas with Hodgkin Reed Sternberg (HRS) morphology: a troubleshooter
  • OFP-13-004-Enhancer Zeste Homolog 2 (EZH2) expression is associated with a shorter time to the first systemic therapy in follicular lymphoma
  • OFP-13-006-Characterisation of atypical dMMR (deficient MisMatch Repair) tumours: a study from a large cohort of 4948 cases
  • OFP-13-008-Novel role of NMI (N-myc interactor) in chemotherapy response through a mitochondrial dysfunction mediated mechanism and as a potential target for breast cancer therapy
  • OFP-13-010-Methylation patterns in dysplasia in inflammatory bowel disease patients
  • OFP-13-011-XIST promoter methylation status as putative molecular biomarker for testicular germ cell tumours
  • OFP-13-012-Detection of EGFR mutations in ctDNA in plasma samples of NSCLC patients by two simultaneously applied methods
  • OFP-14-002-Detailed description of high-risk HPV in situ hybridisation patterns in endocervical adenocarcinoma and correlation with p16 immunohistochemistry
  • OFP-14-003-Programmed death-ligand 1 (PD-L1) in cervical invasive squamous cell carcinoma and squamous intra-epithelial lesions in HIV infected women: comparison with non-infected patients
  • OFP-14-006-Progenitor cells in ovario-fimbrial zone of female uterine adnexa: a potential clue for epithelial tumours pathogenesis
  • OFP-14-007-Diagnostic panel with p16, stathmin1 and laminin-gamma1 for serous tubal intraepithelial carcinoma
  • OFP-14-008-Relationship between microcystic, elongated and fragmented pattern of myometrial invasion and histopathological prognostic factors in endometrioid endometrial carcinoma
  • OFP-14-011-Neuroendocrine tumours involving the cervix: the role of p16 and HPV-genotyping
  • SC-10-001-Prostate cancer grading: over a decade after the 2005 modified system
  • SC-10-002-The big 5 in penile cancer
  • SC-10-004-Future pathological IO-Biomarker: pathologists beyond PD-L1
  • SC-10-005-Digital pathology approach to radical prostatectomy
  • SS-12-001-Case 1
  • SS-12-002-Case 2
  • SS-12-003-Case 3
  • SS-12-004-Case 4
  • SY-21-001-Tumours of the upper GI tract
  • SY-21-002-Tumours of the lower GI tract
  • SY-21-003-Tumours of the liver and biliary tract
  • SY-21-004-Tumours of the pancreas
  • SY-22-002-Historical review of retinoblastoma
  • SY-22-003-Cajal and his studies on retina